KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) Gross Margin (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Gross Margin for 17 consecutive years, with 49.8% as the latest value for Q4 2025.

  • On a quarterly basis, Gross Margin fell 143.0% to 49.8% in Q4 2025 year-over-year; TTM through Dec 2025 was 51.87%, a 185.0% decrease, with the full-year FY2025 number at 51.87%, down 186.0% from a year prior.
  • Gross Margin was 49.8% for Q4 2025 at Bio-Rad Laboratories, down from 52.59% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 58.43% in Q3 2021 to a low of 49.8% in Q4 2025.
  • A 5-year average of 54.21% and a median of 54.07% in 2022 define the central range for Gross Margin.
  • Peak YoY movement for Gross Margin: soared 240bps in 2022, then tumbled -396bps in 2023.
  • Bio-Rad Laboratories' Gross Margin stood at 54.57% in 2021, then dropped by 0bps to 54.37% in 2022, then fell by -1bps to 53.78% in 2023, then fell by -5bps to 51.22% in 2024, then fell by -3bps to 49.8% in 2025.
  • Per Business Quant, the three most recent readings for BIO's Gross Margin are 49.8% (Q4 2025), 52.59% (Q3 2025), and 52.99% (Q2 2025).